Why the study?
Does newly diagnosed diabetes mellitus or impaired glucose tolerance increase the risk of major adverse cardiovascular events in patients post-myocardial infarction?
Population
768 patients without preexisting diabetes mellitus post-myocardial infarction at one centre in Yorkshire…
Comparison
Newly diagnosed diabetes mellitus or impaired… vs Normal glucose tolerance diagnosed on…
Design
Cohort
Follow-up
47.2 ± 9.4 months
Key result
Newly diagnosed diabetes mellitus (HR 2.15) and impaired glucose tolerance (HR 1.54) independently increased the risk of major adverse cardiovascular events compared to normal glucose tolerance post-myocardial infarction.
Authors
Loading...
Routine OGTT post-MI may aid risk stratification; leaves open whether intervention reduces MACE in this group.
Cohort (n=768)
No
Does newly diagnosed diabetes mellitus or impaired glucose tolerance increase the risk of major adverse cardiovascular events in patients post-myocardial infarction?
Hazard Ratio: 2.15 (95% CI 1.42–3.24)
Absolute Event Rate: 32.2% vs 14.2%
p-value: p=0.003
Newly diagnosed diabetes mellitus and impaired glucose tolerance identified via pre-discharge OGTT are strong independent predictors of major adverse cardiovascular events in patients post-myocardial infarction.
George et al. (2015) conducted a cohort in Myocardial infarction (n=768). Newly diagnosed diabetes mellitus (NDM) vs. Normal glucose tolerance (NGT) was evaluated on First occurrence of major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal MI, severe heart failure or non-haemorrhagic stroke (HR 2.15, 95% CI 1.42-3.24, p=0.003). Newly diagnosed diabetes mellitus (HR 2.15) and impaired glucose tolerance (HR 1.54) independently increased the risk of major adverse cardiovascular events compared to normal glucose tolerance post-myocardial infarction.